Title: | Antileishmanial Activity of Ampbotericin B Entrapped in Cationic Liposomal Formulation |
Area: | Pharmaceutical Sciences, Life Sciences & Biotechnology, Medical Sciences |
Focus Area: | Treatment of Kala azar |
Patent: | IN264798 |
Social Benefits: | The drug-loaded liposomes have enhanced efficacy as antileishmanial agents and provide improved therapeutic index as compared to the free drug; Safe and stable. Immense therapeutic potential. |
Developing Agency: | CSIR-Indian Institute of Chemical Biology (IICB), West Bengal |
Technology Readiness Index: | Lab Validation |
Email: | director@iicb.res.in |
| Website Link : | http://www.iicb.res.in |
| Source (more info) : | https://t.ly/l_sb |
